Trial Profile
Occurrence of uveitis in patients with Juvenile Idiopathic Arthritis treated with Etanercept, Adalimumab and Methotrexate.
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Methotrexate (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 05 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism